Aptevo Therapeutics (APVO) Operating Leases (2019 - 2026)
Aptevo Therapeutics' Operating Leases was $3.3 million in Q2 2026, down 21.4% from $4.2 million a year earlier and down 6.5% from the prior quarter.
Powered by 
Analysis
Aptevo Therapeutics (APVO) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Operating Leases at Aptevo Therapeutics came in at $3.76 million, down 18.7% from FY2024.
- Operating Leases has now declined for three consecutive years, though with a five-year compound annual growth rate of 9.8% (FY2020 to FY2025).
- In earlier years, Operating Leases was $4.63 million in FY2024 (-14.3%), $5.4 million in FY2023 (-11.5%), $6.1 million in FY2022 (+354.9%) and $1.34 million in FY2021 (-43.2%).
- The Q2 2026 figure marks the lowest quarterly Operating Leases since Q1 2022.
- Compared with a year earlier, Operating Leases has declined for 13 straight quarters, with an average decline of 17.1% over the last eight quarters.
- The best year-over-year quarter for Operating Leases over five years was Q1 2023 (growth of 436.4%); the worst was Q1 2022 (a decline of 48.1%).
- Per Business Quant data, APVO's Operating Leases in the three quarters before Q2 2026 was $3.53 million (Q1 2026), $3.76 million (Q4 2025) and $4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Aptevo Therapeutics | 2.71 Mn | -64.29 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.30 Mn |
| Mar 31, 2026 | 3.53 Mn |
| Dec 31, 2025 | 3.76 Mn |
| Sep 30, 2025 | 4.00 Mn |
| Jun 30, 2025 | 4.20 Mn |
| Mar 31, 2025 | 4.40 Mn |
| Dec 31, 2024 | 4.63 Mn |
| Sep 30, 2024 | 4.80 Mn |
| Jun 30, 2024 | 5.00 Mn |
| Mar 31, 2024 | 5.20 Mn |
| Dec 31, 2023 | 5.40 Mn |
| Sep 30, 2023 | 5.60 Mn |
| Jun 30, 2023 | 5.70 Mn |
| Mar 31, 2023 | 5.90 Mn |
| Dec 31, 2022 | 6.10 Mn |
| Sep 30, 2022 | 6.20 Mn |
| Jun 30, 2022 | 6.40 Mn |
| Mar 31, 2022 | 1.10 Mn |
| Dec 31, 2021 | 1.34 Mn |
| Sep 30, 2021 | 1.61 Mn |
API Access
Aptevo Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=APVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "APVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=APVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();